Release Date: Tuesday April 11, 2017    
Expiration Date: Wednesday April 11, 2018

Educational Overview
Opioids play an important role in the management of moderate-to-severe pain and the use of opioid medications has steadily increased over the past few decades. With the growing use of opioids, there has been a correlating increase in opioid abuse, diversion, and misuse. To combat opioid abuse, a multifaceted approach is needed that can include the use of abuse-deterrent formulations (ADFs). ADFs can employ various technologies, such as physical/chemical barriers to prevent crushing or extraction, as well as the use of an agonist/antagonist combination that neutralizes the opioid effect if manipulated. Though the use of ADFs can be an important component in ensuring the responsible use of opioids, the incorporation of ADFs into pain management decisions will require a thorough understanding of the available formulations, including the technologies utilized, dosing for optimal effectiveness, and safety considerations.

Pharmacists are being called to be active members of the interprofessional healthcare teams when managing patients with chronic pain. Thus, they must have the confidence and competence to communicate with fellow healthcare providers and patients regarding the latest options in pain management, including advanced technologies used in ADFs. This program reviews the burden of opioid abuse in today’s society while providing an overview of the current and emerging ADF technologies. This program also highlights the role of pharmacists in guiding pain management decisions as part of an interprofessional healthcare team.

Target Audience
This continuing pharmacy education activity is planned to meet the needs of pharmacists in a variety of practice settings, including managed-care organizations, large and small health systems, outpatient clinics, community pharmacies, and academia. This activity would be especially beneficial for pharmacists, clinical specialists, managers, administrators, and educators who are interested and involved in pain management, new drug therapies, and improving the care of patients with chronic pain.

 

  

Learning Objectives
Upon completing this activity, participants will be able to:

  • Discuss the burden of opioid misuse and abuse on the individual and society
  • Describe current and emerging abuse-deterrent technologies utilized in opioid medications
  • Evaluate the role of abuse-deterrent formulations of opioid medications when making pain management decisions

Educational Format
This webcast on demand is based on the CPE Satellite Symposium conducted at APhA2017.

Note: If you have received credit for attending the live symposium by the same name, you are not eligible to apply for credit for this online version.

The webcast on demand consists of following topics:

The Pharmacist: A Part of the Solution
Understanding Current and Emerging
Abuse-Deterrent Formulations
The Pharmacist Role in Responsible Use
of Opioid Medications
Take-Home Messages

 

Faculty

Gregory L. Holmquist, PharmD, CPE

Certified Pain Educator
Board Certified Oncology Pharmacist
Pain Management /
Palliative Care Pharmacist Specialist
Hospice Consultant
Chronic Non-cancer Pain Team
LTC Elderly Pain Consultant
Private Pain Management Consultant

Seattle, WA
 

 

 

Accreditation

Pharmacists
Center for Independent Healthcare Education is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education. Center has assigned 1.5 contact hours (0.15 CEUs) of continuing pharmacy education credits for participating in this activity.

ACPE UAN:  0473-9999-17-005-H01-P
Activity type: Knowledge-based

For questions regarding the accreditation of this activity, please contact us at info@jointsponsor.com

Method of Participation and Instruction for Credit

  1. Review the entire CE information including target audience, learning objectives, and disclosures.
  2. Review the activity.
  3. Complete the Post Test, Evaluation, and Credit Application Form.
  4. Please note that to receive credit you must achieve a score of at least 70%.
  5. The information that you participated will be uploaded to CPEMonitor and you will be able to access your credits from the profile you set up with NABP. For more information, please visit http://www.nabp.net/.

 

Disclosure of Conflicts of Interest
In accordance with policies set forth by the Accreditation Council for Continuing Medical Education (ACCME), Center for Independent Healthcare Education requires all faculty members and spouses/significant others with an opportunity to affect the content of a continuing education activity to disclose any relevant financial relationships during the past 12 months with commercial interests. A commercial interest is any entity producing, marketing, reselling or distributing health care goods or services consumed by or used on patients. Relationships with commercial interests and conflicts of interest resulting from those relationships must be revealed to the audience and resolved prior to the activity.

Relevant relationships include roles such as speaker, author, consultant, independent contractor (including research), employee, investor, advisory committee member, board member, review panelist, and investigator. If a potential speaker or author indicates a possible conflict of interest, the conflict will be resolved by choosing another speaker or author for that topical area, or the slides, handouts, and/or monograph will be reviewed and approved by a qualified commercially-disinterested peer.

 

  

Disclosures
Gregory L. Holmquist, PharmD has relevant financial relationships with the following commercial interests:
            Speakers Bureau: Depomed
Dr. Holmquist does not discuss off-label uses of any products.

No other speakers, authors, planners or content reviewers have any relevant financial relationships to disclose.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Fee
There is no fee to participate in this activity.

Hardware/Software Requirements
Microsoft Internet Explorer, Mozilla Firefox, Apple Safari or Google Chrome with the QuickTime Plug-in
Note: Please disable any “pop-up blocker” features.

Software/Hardware
Adobe® Reader version 7 or above to view PDF files (If you do not have Adobe® Reader, you can download it for free from Adobe.com)
Adobe Flash Player version 10 or above to view multimedia content (If you do
not have Adobe Flash Player, you can download it for free from Adobe.com)

Connection Speed
Cable, DSL, or better of at least 300 kbps

System Check
Please e-mail any questions or concerns to info@vemcomeded.com.

Copyright Statement
Copyright © 2017 Vemco MedEd, LLC. All Rights Reserved. Permission for accreditation use granted to Center for Independent Healthcare Education.

Privacy Policy
http://www.vemcomeded.com/privacy.asp

Joint Providership
This activity is jointly provided by Center for Independent Healthcare Education and Vemco MedEd.

Commercial Support

This activity is supported by an educational grant from Teva Pharmaceuticals.

 


 

  

By clicking below, I acknowledge that I have read the entire CE information.